Lipocine Inc reports results for the quarter ended in June - Earnings Summary

Lipocine

10/08/2023 15:09

* Lipocine Inc  LPCN.OQ  reported a quarterly adjusted loss
of 68
cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 64 cents per share.
    * Reported revenue was zero​; analysts expected $284.00
thousand. 
    * Lipocine Inc's reported EPS for the quarter was a loss
of 68
cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Lipocine Inc shares had risen by 1.0% this quarter and
lost 24.7% so far this year.
    * The company reported a quarterly loss of $3.55 million.
    * Wall Street's median 12-month price target for Lipocine
Inc is
$36.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 02:09 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.64          -0.68          Missed
 Mar. 31 2023      -0.42          -0.68          Missed
 Dec. 31 2022      -0.51          -0.51          Met
 Sep. 30 2022      -0.57          -0.51          Beat